Cell Source, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 57.4% | 57.4% | -1,008.1% |
| FY2021 | 55.7% | 55.7% | -1,744.1% |
| FY2022 | 40.9% | 40.9% | -1,260.9% |
| FY2023 | 34.1% | 34.1% | -2,726.4% |
| FY2024 | 24.3% | 24.3% | -1,575.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 57.4% | 57.4% | -1,008.1% |
| FY2021 | 55.7% | 55.7% | -1,744.1% |
| FY2022 | 40.9% | 40.9% | -1,260.9% |
| FY2023 | 34.1% | 34.1% | -2,726.4% |
| FY2024 | 24.3% | 24.3% | -1,575.1% |